T · NYSE
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $125.65B | $122.34B | $122.43B | $120.74B | $134.04B | $143.05B | $181.19B | $170.76B |
| Selling, General & Administrative | $28.94B | $28.41B | $28.87B | $28.96B | $29.67B | $30.82B | $39.42B | $36.77B |
| Operating Expenses | $101.49B | $103.29B | $98.97B | $125.33B | $108.14B | $134.68B | $153.24B | $144.66B |
| Operating Income | $24.16B | $19.05B | $23.46B | -$4.59B | $25.90B | $8.37B | $27.95B | $26.10B |
| Interest Expense | — | — | $6.70B | $6.11B | $6.72B | $7.73B | $8.42B | $7.96B |
| Other Income / (Expense) | $2.85B | -$2.35B | -$3.61B | $1.49B | $3.27B | -$8.73B | -$9.49B | -$1.22B |
| Income Before Taxes | $27.01B | $16.70B | $19.85B | -$3.09B | $29.17B | -$354.00M | $18.47B | $24.87B |
| Provision for Income Taxes | $3.62B | $4.45B | $4.22B | $3.78B | $5.39B | $1.17B | $3.49B | $4.92B |
| Net Income | $21.95B | $10.95B | $14.40B | -$8.52B | $20.08B | -$5.18B | $13.90B | $19.37B |
| Basic EPS | $3.04 | $1.49 | $1.97 | -$1.13 | $2.77 | -$0.75 | $1.90 | $2.85 |
| Diluted EPS | $3.04 | $1.49 | $1.97 | -$1.13 | $2.73 | -$0.75 | $1.89 | $2.85 |
| Basic Shares Outstanding | 7.17B | 7.20B | 7.18B | 7.17B | 7.17B | 7.16B | 7.32B | 6.78B |
| Diluted Shares Outstanding | 7.18B | 7.20B | 7.26B | 7.59B | 7.50B | 7.47B | 7.35B | 6.81B |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $2.34 | $2.31 | $2.47 | 10 | ↑7 ↓1 |
| Dec 2027 | $2.57 | $2.43 | $2.78 | 11 | ↑7 ↓1 |
| Dec 2028 | $2.89 | $2.70 | $3.09 | 5 | ↑3 ↓0 |
| Dec 2029 | $3.16 | $3.06 | $3.23 | 3 | ↑1 ↓0 |